Prince Joshua S. 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Common Stock
2025-06-30$1.70/sh+4,882$8,299→ 10,863 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).